The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Open accessAbstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant quickly rose to dominance in mid-2021, displacing other variants, including Alpha. Studies using data from the United Kingdom and India estimated that Delta was 40-80% more transmissible than Alpha, allowing Delta to become the globally dominant variant. However, it was unclear if the ostensible difference in relative transmissibility was due mostly to innate properties of Delta's infectiousness or differences in the study populations. To investigate, we formed a partnership with SARS-CoV-2 genomic surveillance programs from all six New England US states. By comparing logistic growth rates, we found that Delta emerged 37-163% faster than Alpha in early 2021 (37% Massachusetts, 75% New Hampshire, 95% Maine, 98% Rhode Island, 151% Connecticut, and 163% Vermont). We next computed variant-specific effective reproductive numbers and estimated that Delta was 58-120% more transmissible than Alpha across New England (58% New Hampshire, 68% Massachusetts, 76% Connecticut, 85% Rhode Island, 98% Maine, and 120% Vermont). Finally, using RT-PCR data, we estimated that Delta infections generate on average ∼6 times more viral RNA copies per mL than Alpha infections. Overall, our evidence indicates that Delta's enhanced transmissibility could be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on the underlying immunity and behavior of distinct populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581 · cited 4×
“A breakdown of the number of genomes by state and lineage is included in Tables S1–S3.”
InfluentialSelf-citationEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Self-citationA dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Data, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics
Cori, A., Ferguson, N. M., Fraser, C., & Cauchemez, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt133 · Cited by 1,530 · cited 2×
“REAGENT or RESOURCE SOURCE IDENTIFIER Deposited data SARS-CoV-2 genomes GISAID https://www.gisaid.org/ Confirmed COVID-19 cases Johns Hopkins Center for Systems Science and Engineering https://github.com/CSSEGISandData/COVID-19 Estimated COVID-19 infections Covidestim https://covidestim.org/ 2019 U.S. state population…”
InfluentialThe biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009 · cited 1×
“Delta, containing the spike L452R and P681Hmutations (in the receptorbindingdomainandnear the furin cleavage site, respectively) that may affect antibody recognition, was first recognized in India in early 2021 and displaced Alpha as the dominant variant bymid-2021.(5) This shift led to a significant resurgence in COV…”
Genetic Variants of SARS-CoV-2—What Do They Mean?
Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604
Serial interval and incubation period of COVID-19: a systematic review and meta-analysis
Alene, M., Yismaw, L., Assemie, M. A., Ketema, D. B., Gietaneh, W., & Birhan, T. Y. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05950-x · Cited by 354
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
Kissler, S. M., Fauver, J. R., Mack, C., Tai, C. G., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Metti, J., Khullar, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102507 · Cited by 335
Self-citation
Cited by
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Carabelli, A. M., Peacock, T. P., Thorne, L. G., Harvey, W. T., Hughes, J., COVID-19 Genomics UK Consortium, de Silva, T. I., Peacock, S. J., Barclay, W. S., de Silva, T. I., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00841-7 · Cited by 1,291
SARS-CoV-2 viral load and shedding kinetics
Puhach, O., Meyer, B., & Eckerle, I. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00822-w · Cited by 424
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Zhang, J., Xiao, T., Cai, Y., Lavine, C. L., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A., Mayer, M. L., et al. (2021) · Science · doi:10.1126/science.abl9463 · Cited by 296
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
Yin, W., Xu, Y., Xu, P., Cao, X., Wu, C., Gu, C., He, X., Wang, X., Huang, S., Yuan, Q., et al. (2022) · Science · doi:10.1126/science.abn8863 · Cited by 283
Metadata
- Authors
- Earnest, R., Uddin, R., Matluk, N., Renzette, N., Turbett, S. E., Siddle, K. J., Loreth, C., Adams, G., Tomkins-Tinch, C. H., Petrone, M. E., Rothman, J. E., Breban, M. I., Koch, R. T., Billig, K., Fauver, J. R., Vogels, C. B. F., Bilguvar, K., De Kumar, B., Landry, M. L., Peaper, D. R., Kelly, K., Omerza, G., Grieser, H., Meak, S., Martha, J., Dewey, H. B., Kales, S., Berenzy, D., Carpenter-Azevedo, K., King, E., Huard, R. C., Novitsky, V., Howison, M., Darpolor, J., Manne, A., Kantor, R., Smole, S. C., Brown, C. M., Fink, T., Lang, A. S., Gallagher, G. R., Pitzer, V. E., Sabeti, P. C., Gabriel, S., MacInnis, B. L., Altajar, A., DeJesus, A., Brito, A., Watkins, A. E., Muyombwe, A., Blumenstiel, B. S., Neal, C., Kalinich, C. C., Liu, C., Loreth, C., Castaldi, C., Pearson, C., Bernard, C., Nolet, C. M., Ferguson, D., Buzby, E., Laszlo, E., Reagan, F. L., Vicente, G., Rooke, H. M., Munger, H., Johnson, H., Tikhonova, I. R., Ott, I. M., Razeq, J., Meldrim, J. C., Brown, J., Wang, J., Vostok, J., Beauchamp, J. P., Grimsby, J. L., Hall, J., Messer, K. S., Larkin, K. L., Vernest, K., Madoff, L. C., Green, L. M., Webber, L., Gagne, L., Ulcena, M. A., Ray, M. C., Fisher, M. E., Barter, M., Lee, M. D., DeFelice, M. T., Cipicchio, M. C., Smith, N. L., Lennon, N. J., Fitzgerald, N. A., Kerantzas, N., Hui, P., Harrington, R., Downing, R., Haye, R., Lynch, R., Anderson, S. E., Hennigan, S., English, S., Cofsky, S., Clancy, S., Mane, S., Ash, S., Baez, S., Fleming, S., Murphy, S., Chaluvadi, S., Alpert, T., Rivard, T., Schulz, W., Mandese, Z. M., Tewhey, R., Adams, M. D., Park, D. J., Lemieux, J. E., & Grubaugh, N. D.
- Venue
- Cell Reports Medicine
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 3
- Issue
- 4
- Pages
- 100583
- ISSN
- 2666-3791 (ISSN-L)
- OpenAlex
- W4225297917
- Cited by
- 210
- References
- 12
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. https://app.cochat.ai/papers/10.1016/j.xcrm.2022.100583
- The paper
- Earnest, R., Uddin, R., Matluk, N., Renzette, N., Turbett, S. E., Siddle, K. J., Loreth, C., Adams, G., Tomkins-Tinch, C. H., Petrone, M. E., Rothman, J. E., Breban, M. I., Koch, R. T., Billig, K., Fauver, J. R., Vogels, C. B. F., Bilguvar, K., De Kumar, B., Landry, M. L., . . . Grubaugh, N. D. (2022). Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2022.100583
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.